SIM
HALO icon

Sentry Investment Management’s Halozyme HALO Stock Holding History

Sentry Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,482
Closed -$793K – 502
2021
Q3 		$793K Sell
19,482
-1,518
-7% -$63.5K 0.23% 107
2021
Q2 		$954K Buy
+21,000
New +$929K 0.24% 103

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sentry Investment Management's HALO Position: Q4 2021 in Review

Sentry Investment Management sold out of Halozyme (HALO) in Q4 2021, closing a stake of 19,482 shares — an estimated $793K sold.

Sentry Investment Management first reported a position in HALO in Q2 2021 and held it in 2 quarters. The position peaked at $954K in Q2 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

  • Sentry Investment Management reported no remaining Halozyme position as of Q4 2021 after selling out during the quarter.
  • Sentry Investment Management sold 19,482 Halozyme shares in Q4 2021, an estimated $793K.
  • Sentry Investment Management first reported a position in Halozyme in Q2 2021 and held it in 2 quarters.
  • Sentry Investment Management's Halozyme position peaked at $954K in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on Sentry Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.